Ukraine may cancel marketing authorizations for pharmaceuticals held by companies with ties to pharmaceutical manufacturing in Russia or Belarus
On 3 May 2022, the parliament of Ukraine adopted in the first reading the draft law No. 7313 (“Draft Law“), aiming to prevent the turnover...